As shown in Figure 4B, CD4+CD25+Foxp3+ Tregs were also elevated in AML patients compared with controls (4.31 ± 1.41%; 0.97 ± 0.23%, P < 0.01; respectively). The gene discussed is FOXP3; the disease is acute myeloid leukemia.